A Multicentre Trial to Compare Two Articulating Bearing Surfaces as Used in Cementless Primary Hip Arthroplasty

NCT ID: NCT01247038

Last Updated: 2017-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2015-07-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to demonstrate the non-inferiority of the ceramic-on-metal articulation using large diameter bearings (38mm to 60mm) compared to the metal on metal articulation using the same cup in regards to the composite clinical success (CCS) rate at 2 years postoperatively (delta = 10% minimum clinically significant difference in rates).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This multicentre randomised controlled trial will compare the clinical outcome of the ceramic-on-metal articulation against a metal-on-metal articulation using the same Recap Acetabular cup.

The metal ion release will be evaluated at predetermined postoperative intervals during the first 36 months. A trial will be conducted as a clinical trial in accordance with the Medical Devices Directive 93/42/EEC (2002).

A total of 150 patients have to be recruited from the South African centre (2 groups)

The initial study assessment period will be 48 months; 24 months recruitment and 24 months follow-up. The follow-up reviews will be at 6 weeks, 6 months, 1 year, 2 years and 3 years. A 5 year and 10 year clinical review will also be carried out with all patients.

An assessment of incidences of adverse events and metal ion release concentrations will be made when all patients are at 6 months postoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Metal on ceramic articulation

The arm consists of patients with Ceramic femoral heads articulating with metal acetabular cups

Group Type EXPERIMENTAL

Metal on ceramic articulation

Intervention Type DEVICE

Metal on ceramic articulation against metal-on-metal articulation using the same Recap Acetabular cup

Metal-on-metal

The arm consists of patients with Metal femoral heads articulating with metal acetabular cups

Group Type ACTIVE_COMPARATOR

Metal-on-Metal

Intervention Type DEVICE

Metal on Metal articulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Metal on ceramic articulation

Metal on ceramic articulation against metal-on-metal articulation using the same Recap Acetabular cup

Intervention Type DEVICE

Metal-on-Metal

Metal on Metal articulation

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MagnumC Magnum

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary total hip replacement
* Patient with degenerative joint disease (inflammatory or non-inflammatory) or any of the composite diagnoses of osteoarthritis,avascular necrosis, legg perthes, rheumatoid arthritis, diastrophic variant, fracture of the pelvis, fused hip, slipped capital epiphysis, subcapital fractures, traumatic arthritis
* Patients preoperative Harris hip score \< 80 points
* Patients with limited co-morbidity - ASA I - III
* Patients with normal urea and electrolyte levels and creatinine levels
* Patients must be able to understand instructions and be willing to return for follow-up
* Patients willing to provide blood and urine samples for metal ion analysis at follow-up

Exclusion Criteria

* Patient preoperative Harris hip score \> 80 points
* Pre-existing metal implants
* Patients with significant co-morbidity - ASSA IV - V
* Dementia and inability to understand and follow instructions
* Neurological conditions affecting movement
* Women younger than 45 years old
* Presence of symptomatic arthritis in other lower limb joints
* Patients requiring smaller than 38mm and larger than 60mm diameter femoral heads
* Patients taking NSAIDs and / all drugs that will affect bone metabolism
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Orthopaedic Hospital & Rehabilitation Clinic of "Dr Miroslav Zotovic"

Banja Luka, , Bosnia and Herzegovina

Site Status

Johannesburg Hospital

Parktown, , South Africa

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bosnia and Herzegovina South Africa

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Biomet UK Healthcare Ltd

Identifier Type: OTHER

Identifier Source: secondary_id

BMETEU.CR.EU33

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Avenir® Cemented Hip Stem - PMCF
NCT03396224 ACTIVE_NOT_RECRUITING